Clinical trials recruiting for Head and Neck Squamous Cell Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| A2B395 | 1 |
| EPI-326 | 1 |
| Pembrolizumab | 1 |
| XB010 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| New York | 3 |
| Florida | 2 |
| Missouri | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Arizona | 1 |
| District of Columbia | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Minnesota | 1 |
| New Jersey | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Study of XB010 in Subjects With Solid Tumors
Related conditions
Trials recruiting for Head and Neck Squamous Cell Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Head and Neck Squamous Cell Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.